(0.31%) 5 115.87 points
(0.29%) 38 352 points
(0.37%) 15 986 points
(-0.95%) $83.05
(5.36%) $2.03
(0.34%) $2 355.20
(0.47%) $27.67
(4.15%) $960.35
(-0.27%) $0.932
(-0.45%) $10.97
(-0.59%) $0.796
(1.63%) $93.37
3 days till quarter result
(bmo 2024-05-02)
Expected move: +/- 6.07%
@ $2.25
発行日: 14 2月 2024 @ 23:30
リターン: -21.64%
前回のシグナル: 2月 14 - 04:04
前回のシグナル:
リターン: 5.14 %
Live Chart Being Loaded With Signals
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety...
Stats | |
---|---|
本日の出来高 | 572 360 |
平均出来高 | 1.58M |
時価総額 | 319.62M |
EPS | $0 ( 2024-03-05 ) |
次の収益日 | ( $-0.0400 ) 2024-05-02 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -8.40 |
ATR14 | $0.00500 (0.28%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-12 | Green Kevin Dennis | Buy | 21 666 | Common Stock |
2024-03-13 | Green Kevin Dennis | Sell | 21 058 | Common Stock |
2024-03-14 | Green Kevin Dennis | Sell | 21 497 | Common Stock |
2024-03-12 | Green Kevin Dennis | Sell | 21 666 | Restricted Stock Unit |
2024-03-12 | Moore Carol | Buy | 11 666 | Common Stock |
INSIDER POWER |
---|
53.73 |
Last 100 transactions |
Buy: 4 007 373 | Sell: 1 157 608 |
ボリューム 相関
Cerus Corp 相関
10 最も負の相関 | |
---|---|
ARIZ | -0.918 |
PEP | -0.916 |
LBPH | -0.915 |
TWCB | -0.911 |
GLLI | -0.91 |
XPDB | -0.909 |
AVAC | -0.909 |
HWEL | -0.904 |
MDLZ | -0.903 |
PUCK | -0.901 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Cerus Corp 相関 - 通貨/商品
Cerus Corp 財務諸表
Annual | 2023 |
収益: | $156.37M |
総利益: | $84.00M (53.72 %) |
EPS: | $-0.210 |
FY | 2023 |
収益: | $156.37M |
総利益: | $84.00M (53.72 %) |
EPS: | $-0.210 |
FY | 2022 |
収益: | $162.05M |
総利益: | $87.09M (53.75 %) |
EPS: | $-0.240 |
FY | 2021 |
収益: | $159.52M |
総利益: | $96.04M (60.21 %) |
EPS: | $-0.316 |
Financial Reports:
No articles found.
Cerus Corp
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。